OTC Markets OTCPK - Delayed Quote USD

Wesana Health Holdings Inc. (WSNAF)

0.0345
+0.0215
+(165.38%)
At close: May 16 at 4:00:00 PM EDT
Loading Chart for WSNAF
  • Previous Close 0.0130
  • Open 0.0130
  • Bid 0.0103 x --
  • Ask 0.0500 x --
  • Day's Range 0.0130 - 0.0130
  • 52 Week Range 0.0025 - 0.1500
  • Volume 100
  • Avg. Volume 13,322
  • Market Cap (intraday) 721,750
  • Beta (5Y Monthly) -0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.

www.wesanahealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WSNAF

View More

Performance Overview: WSNAF

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

WSNAF
61.37%
S&P/TSX Composite index (^GSPTSE)
5.49%

1-Year Return

WSNAF
320.73%
S&P/TSX Composite index (^GSPTSE)
16.47%

3-Year Return

WSNAF
85.97%
S&P/TSX Composite index (^GSPTSE)
28.53%

5-Year Return

WSNAF
98.43%
S&P/TSX Composite index (^GSPTSE)
77.42%

Compare To: WSNAF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WSNAF

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    721.75k

  • Enterprise Value

    924.82k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -22.43%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -543.31k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    46.93k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    582.16k

Research Analysis: WSNAF

View More

Company Insights: WSNAF

Research Reports: WSNAF

View More

People Also Watch